Nocturne Acquisition Corporation Asset Turnover Ratio (MBTCU), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nocturne Acquisition Corporation  (NASDAQ: MBTCU)
 

Nocturne Acquisition Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2023, Nocturne Acquisition Corporation has not recorded any assets.
Visit Nocturne Acquisition Corporation Balance sheet

Within sector Nocturne Acquisition Corporation achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MBTCU Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -82.3 % -82.86 % -81.88 % -81.87 % 2.11 %
Y / Y Revenue Change - - 2264.79 % - 35679.85 %
Asset Turnover Ratio (TTM) - - 0.02 0.01 0.01
MBTCU's Total Ranking # # # # #
Seq. Asset Change 5.01 % -4.73 % -0.22 % -82.27 % 1.66 %
Seq. Revenue Change - - 105.2 % -74.78 % 237.88 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




MBTCU Company Profile • Back to MBTCU Efficiency Comparisons • Compare MBTCU Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Cervomed Inc   0.05 $ 1.526  Millions$ 28.712  Millions
C4 Therapeutics Inc   0.05 $ 20.349  Millions$ 383.724  Millions
Tff Pharmaceuticals Inc  0.05 $ 0.932  Millions$ 17.697  Millions
Clearside Biomedical Inc   0.05 $ 2.211  Millions$ 42.401  Millions
Ideaya Biosciences Inc   0.05 $ 23.484  Millions$ 453.304  Millions
Asensus Surgical Inc   0.05 $ 4.667  Millions$ 90.419  Millions
Bicycle Therapeutics Plc  0.05 $ 24.830  Millions$ 483.066  Millions
Celularity Inc   0.05 $ 14.788  Millions$ 291.773  Millions
Atara Biotherapeutics Inc   0.05 $ 13.578  Millions$ 278.433  Millions
Vir Biotechnology Inc   0.05 $ 118.803  Millions$ 2,439.198  Millions
Editas Medicine Inc   0.05 $ 24.611  Millions$ 506.257  Millions
Cue Biopharma Inc   0.05 $ 3.820  Millions$ 78.754  Millions
Gritstone Bio Inc   0.05 $ 10.225  Millions$ 215.137  Millions
Verrica Pharmaceuticals Inc   0.05 $ 3.204  Millions$ 68.177  Millions
Vystar Corporation  0.05 $ 0.417  Millions$ 9.103  Millions
Quantum Cyber N v   0.05 $ 0.874  Millions$ 19.248  Millions
Syros Pharmaceuticals Inc   0.05 $ 8.795  Millions$ 194.647  Millions
Roivant Sciences Ltd   0.04 $ 103.153  Millions$ 2,294.230  Millions
Lexaria Bioscience Corp   0.04 $ 0.226  Millions$ 5.253  Millions
Aclarion Inc   0.04 $ 0.084  Millions$ 2.081  Millions
Co diagnostics Inc   0.04 $ 4.658  Millions$ 115.392  Millions
Longeveron Inc   0.04 $ 0.767  Millions$ 19.485  Millions
Arch Therapeutics Inc   0.04 $ 0.076  Millions$ 1.930  Millions
Armata Pharmaceuticals Inc   0.04 $ 4.052  Millions$ 104.647  Millions
Lucid Diagnostics Inc   0.04 $ 1.500  Millions$ 39.341  Millions
Ambrx Biopharma Inc   0.04 $ 8.602  Millions$ 227.259  Millions
Intellia Therapeutics Inc   0.04 $ 51.765  Millions$ 1,376.148  Millions
Bolt Biotherapeutics Inc   0.04 $ 7.198  Millions$ 200.010  Millions
Pavmed Inc   0.04 $ 1.923  Millions$ 53.742  Millions
Stoke Therapeutics Inc   0.04 $ 9.248  Millions$ 258.668  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.